Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Rheumatoid Arthritis Diagnostic Tests Market – Insights

Rheumatoid arthritis (RA) is an autoimmune disease in which the body’s own immune system attacks its joint tissues, which leads to inflammation of joint lining. Such inflammation of joint lining causes pain, stiffness, swelling, warmth, and redness.

Statistics:

The global rheumatoid arthritis diagnostic tests market is estimated to account for US$ 3,480.9 Mn in terms of value by the end of 2027

Global Rheumatoid Arthritis Diagnostic Tests Market: Drivers

Increasing prevalence of RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period. For instance, according to the study, “Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017”, published in the journal Annals of the Rheumatic Diseases, in November 2019, the age-standardized point prevalence and annual incidence rates of RA were 246.6 and 14.9 in 2017, which increased by 7.4% and 8.2% from 1990, respectively.

Moreover, increasing expenditure for the treatment and management of RA is also expected to aid in growth of the market. For instance, according to the study, “Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study”, published in the journal PLOS One in January 2019, the annual health expenditures were significantly larger for patients with RA than for controls.

Asia Pacific held dominant position in the global rheumatoid arthritis diagnostic tests market in 2019, accounting for 41.1% share in terms of value, followed by Europe, respectively

Figure 1. Global Rheumatoid Arthritis Diagnostic Tests Market Share (%), by Region, 2019

Rheumatoid Arthritis Diagnostic Tests  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Global Rheumatoid Arthritis Diagnostic Tests Market: Restraints 

Limited specificity and sensitivity of test kits available in the market is expected to hinder growth of the global rheumatoid arthritis diagnostic tests market.

Moreover, lack of effective drugs for the treatment of RA is also expected to limit growth of the market.

Global Rheumatoid Arthritis Diagnostic Tests Market: Opportunities 

Introduction of cost effective and reliable test kits is expected to offer lucrative growth opportunities for players in the market. Presently, there are no effective diagnosis measures available for rheumatoid arthritis. The unavailability of effective diagnostic tools has triggered the need for cost effective and more reliable test kits. As a result, the companies operating in this market are now focusing on the development of cost-effective and reliable test methods.

Moreover, R&D of biomarker-based diagnostic methods for RA is also expected to aid in growth of the market. For instance, in February 2020, researchers from Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Germany, reported that serum markers can be used to detect inflammation in patients in joint diseases.

Rheumatoid Arthritis Diagnostic Tests  | Coherent Market Insights

The hospitals segment of global rheumatoid arthritis diagnostic tests market was valued at US$ 614.1 Mn in 2019 and is forecast to reach a value of US$ 1,062.8 Mn by 2027 at a CAGR of 7.1% between 2019 and 2027

Market Trends/Key Takeaways

In the recent past, the techniques for diagnosing RA have made significant progress in terms of rapid outcomes. The serology test is now being performed on the rapid diagnosis test platform, which helps in conducting RA test within the stipulated time. A large number of pathology centers are increasingly relying on such rapid diagnostic tools, owing to increasing in-patient visit for RA testing.

Application of biomarker test for diagnosing RA is at an early stage of development. Many companies are focusing on the development of biomarker test, owing to the limited efficacy of test kits available in the current market. Presently, there is no biochemical test available for the diagnosis of RA. However, Rheumatoid Factor (RF) and Anti–Cyclic Citrullinated Peptide (anti–CCP) antibodies test require more refinement to improve their clinical utility.

Rheumatoid Arthritis Diagnostic Tests  | Coherent Market Insights

Global Rheumatoid Arthritis Diagnostic Tests Market: Competitive Landscape

Major players operating in the global rheumatoid arthritis diagnostic tests market include, Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.

Global Rheumatoid Arthritis Diagnostic Tests Market: Key Developments

Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in March 2020, WorldCare Clinical, LLC, an independent CRO offering imaging in clinical trials partnered with Navidea Biopharmaceuticals, Inc. to offer imaging service following FDA approval of Navidea’s RA diagnostic.

Rheumatoid Arthritis is an autoimmune disease which leads joint pain due to inflammation of joint lining. The condition usually affects the hands, feet and wrists. Blood tests commonly used to diagnose RA include, rheumatoid factor anti-cyclic citrullinated peptide, C - reactive protein (CRP), and Erythrocyte Sedimentation Rate (ESR). Increasing prevalence of RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period. Furthermore, development of new blood tests for RA is also expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period

Key features of the study:

  • This report provides in-depth analysis of the Rheumatoid Arthritis Diagnostic Tests market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Rheumatoid Arthritis Diagnostic Tests market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Rheumatoid Arthritis Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market

Detailed Segmentation:

  • Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:
    • Serology Test
      • Erythrocyte Sedimentation Rate (ESR)
      • Rheumatoid Factor (RF)
      • Anti-cyclic Citrullinated Peptide (anti-CCP)
      • Antinuclear Antibody (ANA)
      • Uric Acid
      • Other Tests
    • Monitoring RA Treatment Efficiency Tests
      • Salicylate Level Count
      • Muscle Enzyme Tests (CPK, Aldolase)
      • Creatinine Test
  • Rheumatoid Arthritis Diagnostic Tests Market, By End User:
    • Diagnostic Laboratories
    • Private Laboratories
    • Public Laboratories
    • Ambulatory Surgical Centers
  • Rheumatoid Arthritis Diagnostic Tests Market, By Region:
    • North America
      • By Test Type:
        • Serology Test
          • Erythrocyte Sedimentation Rate (ESR)
          • Rheumatoid Factor (RF)
          • Anti-cyclic Citrullinated Peptide (anti-CCP)
          • Antinuclear Antibody (ANA)
          • Uric Acid
          • Other Tests
        • Monitoring RA Treatment Efficiency Tests
          • Salicylate Level Count
          • Muscle Enzyme Tests (CPK, Aldolase)
          • Creatinine Test
      • By End User
        • Diagnostic Laboratories
        • Private Laboratories
        • Public Laboratories
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Test Type:
        • Serology Test
          • Erythrocyte Sedimentation Rate (ESR)
          • Rheumatoid Factor (RF)
          • Anti-cyclic Citrullinated Peptide (anti-CCP)
          • Antinuclear Antibody (ANA)
          • Uric Acid
          • Other Tests
        • Monitoring RA Treatment Efficiency Tests
          • Salicylate Level Count
          • Muscle Enzyme Tests (CPK, Aldolase)
          • Creatinine Test
      • By End User
        • Diagnostic Laboratories
        • Private Laboratories
        • Public Laboratories
        • Ambulatory Surgical Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Test Type:
        • Serology Test
          • Erythrocyte Sedimentation Rate (ESR)
          • Rheumatoid Factor (RF)
          • Anti-cyclic Citrullinated Peptide (anti-CCP)
          • Antinuclear Antibody (ANA)
          • Uric Acid
          • Other Tests
        • Monitoring RA Treatment Efficiency Tests
          • Salicylate Level Count
          • Muscle Enzyme Tests (CPK, Aldolase)
          • Creatinine Test
      • By End User
        • Diagnostic Laboratories
        • Private Laboratories
        • Public Laboratories
        • Ambulatory Surgical Centers
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Serology Test
          • Erythrocyte Sedimentation Rate (ESR)
          • Rheumatoid Factor (RF)
          • Anti-cyclic Citrullinated Peptide (anti-CCP)
          • Antinuclear Antibody (ANA)
          • Uric Acid
          • Other Tests
        • Monitoring RA Treatment Efficiency Tests
          • Salicylate Level Count
          • Muscle Enzyme Tests (CPK, Aldolase)
          • Creatinine Test
      • By End User
        • Diagnostic Laboratories
        • Private Laboratories
        • Public Laboratories
        • Ambulatory Surgical Centers
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Test Type:
        • Serology Test
          • Erythrocyte Sedimentation Rate (ESR)
          • Rheumatoid Factor (RF)
          • Anti-cyclic Citrullinated Peptide (anti-CCP)
          • Antinuclear Antibody (ANA)
          • Uric Acid
          • Other Tests
        • Monitoring RA Treatment Efficiency Tests
          • Salicylate Level Count
          • Muscle Enzyme Tests (CPK, Aldolase)
          • Creatinine Test
      • By End User
        • Diagnostic Laboratories
        • Private Laboratories
        • Public Laboratories
        • Ambulatory Surgical Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Serology Test
          • Erythrocyte Sedimentation Rate (ESR)
          • Rheumatoid Factor (RF)
          • Anti-cyclic Citrullinated Peptide (anti-CCP)
          • Antinuclear Antibody (ANA)
          • Uric Acid
          • Other Tests
        • Monitoring RA Treatment Efficiency Tests
          • Salicylate Level Count
          • Muscle Enzyme Tests (CPK, Aldolase)
          • Creatinine Test
      • By End User
        • Diagnostic Laboratories
        • Private Laboratories
        • Public Laboratories
        • Ambulatory Surgical Centers
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Diagnostics (Abbott Laboratories) *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Antibodies Inc.
    • Beckman Coulter, Inc.
    • Euro Diagnostica AB
    • F. Hoffmann-La Roche Ltd.
    • Qiagen NV
    • Siemens Healthcare Gmb
    • Thermo Fisher Scientific Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippets, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Serology Test
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Erythrocyte Sedimentation Rate (ESR)
        • Rheumatoid Factor (RF)
        • Anti-cyclic Citrullinated Peptide (anti-CCP)
        • Antinuclear Antibody (ANA)
        • Uric Acid
        • Other Tests
    • Monitoring RA Treatment Efficiency Tests
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Salicylate Level Count
        • Muscle Enzyme Tests (CPK, Aldolase)
        • Creatinine Test
  5. Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Private Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Public Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Rheumatoid Arthritis Diagnostic Tests Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • Abbott Diagnostics (Abbott Laboratories)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Antibodies Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Beckman Coulter, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Euro Diagnostica AB
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Qiagen NV
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthcare GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 18 figures on “Rheumatoid Arthritis Diagnostic Tests Market - Global forecast to 2027”.

Frequently Asked Questions

This report provides in-depth analysis of the Rheumatoid Arthritis Diagnostic Tests Market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2019 – 2027). The report also provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
Key segments covered in the report include: o By Test Type o By End User o By Region
The report provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
The report profiles leading players in the Global Rheumatoid Arthritis Diagnostic Tests Market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans. Some of the key players operating in the market are; Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner